Introduction
Secretion of bacterial preproteins to the periplasm and outer membrane is mediated by the Sec preprotein 'translocase' or 'translocon' Rapoport, 2007) . Translocase comprises a transmembrane proteinconducting channel built of three polypeptides SecY, SecE and SecG (hereafter SecYEG) (Fig. 1A) (Brundage et al., 1990; Van den Berg et al., 2004) and the SecA ATPase . SecA bound to SecYEG undergoes nucleotide-driven conformational changes thought to represent 'insertion-deinsertion cycles' (Economou and Wickner, 1994; Economou et al., 1995) . In several studies, the peripheral SecA was found in integral membrane states (Economou and Wickner, 1994; Kim et al., 1994; Economou et al., 1995; Chen et al., 1996; protruding as far as the periplasm (van der Does et al., 1996; Ramamurthy and Oliver, 1997; Eichler and Wickner, 1998) . These events are apparently coupled (Economou and Wickner, 1994; Economou et al., 1995) with segmental preprotein transfer across the membrane through SecYEG (Schiebel et al., 1991; Joly and Wickner, 1993) .
Individual high-resolution structures of SecYEG (Van den Berg et al., 2004) (Fig. 1A) and SecA (see Papanikou et al., 2007 and references therein) are available. However, how these subunits assemble to form the functional translocase and which regions of SecYEG associate to SecA remain unknown. Peptide arrays (van der Sluis et al., 2006; Robson et al., 2007) , in vivo sitedirected cysteine mutagenesis and cross-linking (Mori and Ito, 2006) have revealed possible binding sites but yielded some contradicting results and these sites have not been validated by functional assays. Several mutations that affect SecYEG function have been identified (Matsumoto et al., 1997; van der Wolk et al., 1998; Manting et al., 1999) but none of these has been demonstrated to directly affect the functional or physical association of SecA with SecYEG. Monomeric ( Van den Berg et al., 2004) or dimeric (Breyton et al., 2002; Mitra et al., 2005) SecYEG structures have not revealed any obvious 'cavities' or 'clefts' where SecA could insert and become shielded from phospholipids van Voorst et al., 1998) . Addressing SecA-SecYEG topology is further obscured by controversy concerning the functional quaternary structure of the holoenzyme and its components: SecYEG was seen to form monomers (Yahr and Wickner, 2000; Van den Berg et al., 2004) , 'back to back' (Breyton et al., 2002) or 'front to front' (Mitra et al., 2005) dimers and tetramers (Manting et al., 2000; Scheuring et al., 2005) . Moreover, SecA forms monomers Duong, 2003) or dimers (de Keyzer et al., 2005; Jilaveanu et al., 2005) , combinations of monomers or dimers interacting with SecYEG monomers (Tziatzios et al., 2004) or tetramers (Manting et al., 2000; Scheuring et al., 2005) . Atomic resolution structures of the SecASecYEG holoenzyme that could resolve some of these issues are not yet available.
To investigate SecA-SecYEG assembly ab initio without assuming any prior knowledge we used an immobilized peptide array covering the full length of all SecYEG components. Binding was subsequently validated through a combination of quantitative biophysical measurements, mutagenesis and functional assays. This approach identified peripheral regions on SecYEG that interact with SecA, forming a multivalent receptor with several lowaffinity sites. Several of these are essential for catalysis. Binding is electrostatic and involves predominantly cytoplasmic loops and minor membrane-embedded sites.
Both SecA structural domains contribute to binding. SecA-SecYEG association is dynamic and regulated by temperature and nucleotides.
Results

SecYEG peptides that bind SecA
To determine SecYEG segments that interact with SecA we used arrays of 13 residue-long peptides that spanned the entire length of the three polypeptides [Table S1 ; Y01-Y145 (SecY); E01-E39 (SecE); G01-G34 (SecG)]. Purified SecA was incubated with the array at 4°C. SecA that remained bound on the immobilized peptides after extensive washes was blotted onto a polyvinylidene difluoride (PVDF) membrane and immunostained with an a-SecA antiserum (Karamanou et al., 1999) . Binding profiles that A. Surface representation of a model of the E. coli SecYEG structure derived from the original structure of SecYEG from M. jannaschii (Van den Berg et al., 2004) . SecY (yellow) has 10 transmembrane (TM) helices and its 'lateral gate' exposed in the 'front' view. The 10 TM of SecY can be split into two symmetrical halfs (N and C; see 'bottom' view) . ecSecE (blue) contains three helices but only two helices are present in the mjSecYEG complex and these embrace the flexible SecY structure. SecG (green) is almost perpendicular to the plane of the membrane. Structures were visualized with SwissPDBViewer. B. Binding of SecA to a SecYEG peptide array. A representative experiment (as described in Experimental procedures) of SecA binding to the SecYEG peptide array at 4°C, immunostained with an a-SecA antibody (1:100 000 dilution). C. Binding of SecY peptides to SecA in solution. 13mer soluble peptides corresponding to some of the immobilized peptides in the array were synthesized and tested by ITC for binding to SecA.
were reproducible in three to five repeat experiments (e.g. see Fig. 1B ) and were above certain thresholds (see legend to Table S2 ) were analysed further. A few SecYEG peptides bind SecA. These are distributed in five 'regions' along the primary sequence (Fig. 2 , a-e; see below).
The most prominent signals seen were with: SecY peptides (Y04 and Y05, Y116, and SecG (G24). Only Y76 contains hydrophobic residues from one of the 14 transmembrane helices of SecYEG. In most cases SecA bound to a number of overlapping peptides. Thus minimal binding sites could be delimited ( Table S2 ). The apparent binding strength per aminoacyl residue in each peptide was estimated using different antiserum dilutions ( Fig. 2A and Table S2 ).
Quantification of SecA binding to SecYEG peptides
To scrutinize the array data and quantify binding, three peptides displaying the strongest binding (Y05, Y38, Y83) were chemically synthesized and their binding to SecA was measured using isothermal titration calorimetry (ITC) (Fig. 1C) . Three peptides that do not bind SecA in the array (Y33, Y87, Y112) were used as 'controls'. If measurable enthalpy changes occur during a bimolecular interaction ITC can measure them as well as determine the dissociation constant (K D) and the stoichiometries of the complexes. Y05, Y38 and Y83 show significant enthalpy changes and therefore clearly associate with SecA in solution. Complexes display~1:1 stoichiometries and occur with low affinities of 27-280 mM. Alanyl substitution of R113R114K115 in Y38 abolished ITC-detectable binding ( Fig. 1C ; see 'Y38-RKK'). Control peptides showed no detectable binding by ITC (e.g. Y33; Fig. 1C ; Y87 and Y112 are not shown).
Clearly, ITC corroborates that SecYEG peptides identified by the peptide array bind to SecA. These data provide the first demonstration of direct SecA binding to defined, extremely short segments of the protein-conducting channel.
Mapping of SecA docking sites on the three-dimensional structure of SecYEG
We next mapped the sites of SecYEG recognized by SecA ( Fig. 2A ; Greek letters) onto a secondary (Fig. 2G ) and a tertiary surface (Fig. 2H ) model of the Escherichia coli SecYEG derived from the homologous Methanocaldococcus jannaschii structure (Van den Berg et al., 2004) . Practically all of these residues are located in the periphery of SecYEG and their side-chains are exposed and available for possible external interactions. With the exception of two minor sites (g 1 and b1-3 in the periplasmic face of SecYEG), all the binding occurs at cytoplasmic regions of SecY and SecE. Interestingly, such peptides might not be continuous in the primary sequence of a polypeptide yet they assemble in three-dimensional space so as to form composite continuous binding surfaces that we term 'regions' (e.g. d and e). Peptides of region b and g fall on the same side of SecYEG but are otherwise dispersed on the primary sequences. Sites e 1 and e2 derive from the N-terminal (TM1-5) and C-terminal (TM6-10) half of SecY, respectively, but are proximal in three-dimensional space (see Fig. 2H , 'bottom' view). Three regions formed by six cytoplasmic binding sites are the most prominent binders: a1, d1+d2+d3 and e1+e2. Another major site in SecE (aa 30-40) is predicted to be cytoplasmic but cannot be mapped as this region is absent from the mjSecE structure.
The cytoplasmic face of SecY contains a preponderance of charged residues (Fig. 3A) . It is therefore not surprising that in almost all of the sites identified here, charged residues are present (Table S2 ) and important for SecA binding (Fig. 1C , 'Y38-RRK'). Binding of SecA to SecYEG is abrogated when 0.3 M KCl is added, as determined by a membrane flotation assay (Fig. 3I ). Apparently, SecA-SecYEG assembly is driven by a strong electrostatic component.
SecA-SecYEG interaction is modulated by temperature and nucleotides
Nucleotides and temperature control translocase catalysis (Sianidis et al., 2001; Hunt et al., 2002; Schmidt et al., 2000) . Do they also regulate SecA-SecYEG assembly? To test this binding of SecA at 4°C or 37°C in the presence of ADP or the non-hydrolysable ATP analogue AMP-PNP was examined (Fig. S1 ). Results were quantified and mapped onto the primary sequences ( Fig. 2) .
At 4°C, addition of nucleotide causes only minor differences in the profile or strength of peptide binding (compare Fig. 2B and C with Fig. 2A ). However, at 37°C the observed SecA binding footprint on SecYEG was altered in some regions (compare Fig. 2D with Fig. 2A ). This included the appearance of new binding sites (e.g. g 3), the disappearance of others that were prominent at 4°C (e.g. d2/d3) or the shifting of others in the SecYEG primary sequence ( Fig. 2B ; Table S2 ). In general, at 37°C binding occurred to SecYEG sequences that are more hydrophobic and integral to the membrane. ADP addition led to a pattern that closely resembles that seen at 4°C (compare Fig. 2E with Fig. 2B ). The AMP-PNP-derived pattern at 37°C (Fig. 2F ) was intermediate to that of the two previous states.
Collectively, our data demonstrate that SecA can bind to SecYEG as an apoprotein. Nucleotides and temperature can modulate SecA association with certain sites of its polyvalent SecYEG receptor. These dynamic interactions SecA-SecYEG assembly 313 A-F. SecY regions that bind SecA are indicated with residue-level resolution on a linear map of the primary sequence of SecY, SecE and SecG. To facilitate localization of the sites the secondary structure of the proteins is shown at the top including their transmembrane regions (TM), cytoplasmic (C) and periplasmic (P) loops. TM2b is also known as the 'plug' substructure that folds into the channel or can flip out. The height of the bars in the graph indicates apparent 'Binding Strength' expressed in Arbitrary Units. SecA (100 nM) was incubated with the peptide array at the indicated temperature and nucleotide regimes. The Greek letters denote the five distinct binding regions and the numbers in subscript their subsites. The coloured bars highlight the binding regions in the six graphs and are: red (a), orange (b); yellow (g); green (d); and magenta (e). G. The secondary structure elements of SecYEG (as in the top of this figure) were assembled in a two-dimensional transmembrane spanning model derived from the determined structure (Van den Berg et al., 2004) . TMs are denoted here with numbers. The binding sites determined in (A)-(F) are shown here as coloured lines with their Greek alphanumerical labels below. H. Data from (A)-(F) were mapped on a surface model of SecYEG identical to that in Fig. 1A . SecYEG are shown here in grey and only the SecA binding sites are coloured. cannot be dissected with methods assaying for SecA binding overall to membrane-embedded SecYEG (Fig. 3C-G) (Natale et al., 2004) .
Binding of SecA domains onto SecYEG
To identify SecA regions that interact with SecYEG we employed truncated SecA derivatives ( Fig. 4; Fig. S2 ). SecA(9-834) is a fully functional, dimeric SecA that is missing the N-terminal nonapeptide and the C-tail Gelis et al., 2007) ; SecADC is missing the C-terminal domain of SecA (Karamanou et al., 1999; Vrontou et al., 2004) ; the C34 polypeptide encompasses the C-domain of SecA. SecA(9-834) binds to all of the sites determined for wild-type SecA (compare Fig. 4A with Fig. 2A ) with the exception of very weak binding to e 1 and d3 and no detectable binding to a2/3, d2, e2/3 and b2/3. Reproducible binding is seen with either C34 (Fig. 4B) or SecADC (Fig. 4C) indicating that both regions of SecA bind to SecYEG. Remarkably, despite some obvious shifts in the binding frame (e.g. compare e1/3 and a1 in Fig. 4B and C), most of the main cytoplasmic binding regions appear to be used by both SecA substructures.
We next examined whether ADP or/and temperature affect the binding of SecADC to SecYEG (Fig. 4C-F) . SecADC not only retains many of the binding characteristics of the complete SecA but also its binding appears to be similarly regulated by temperature and nucleotide. Binding of C34 could not be detected at 37°C (not shown) suggesting a weaker or more transient interaction with SecYEG at elevated temperature.
Mutations in SecA binding sites abrogate SecY function in vivo
To validate the functional importance of the identified SecA binding sites we used alanine mutagenesis (see Experimental procedures and Supporting information). Mutations were generated on pET610, a plasmid carrying a recombinant secYEG operon (van der . To exclude the possibility of indirect effects caused by the mutations (e.g. instability, reduced membrane insertion, etc.) the amount of SecY in the membranes of all mutants was determined by immunostaining (data not shown). Twenty-one SecY mutant derivatives that were produced to wild-type levels were studied further (Table S3) . A. The electrostatic potential of SecY was determined using the GRASP algorithm. Positive charges are blue and negative charges are red. The grey band in the side view represents non-polar/hydrophobic residues forming the hydrophobic core of the membrane plane. B-I. SecA binding to SecYEG-containing inverted inner membrane vesicles (IMVs). A flotation gradient centrifugation assay was used (Beck et al., 2000; Karamanou et al., 2005; Papanikou et al., 2005) and bound SecA was visualized by immunostaining with a-SecA antibodies. IMVs float inside the gradient in fractions 3-5 . SecA alone (H) sediments to the bottom of the gradient (fractions 7-9) while SecA bound to IMVs floats to fractions 3-5 (B-G).
pET610 restores growth of AF659, an E. coli strain harbouring a cold-sensitive secY mutation (Baba et al., 1990; Smith et al., 2005) , at 20°C, while the vector alone cannot. Sixteen SecY derivatives (Classes I-III) displayed measurable defects in complementation. The location of the most severe mutants is shown in Fig. 5A . Six more mutants (Class IV) with no measurable defects were not studied further. Representative mutants are shown in Fig. 5B (for a complete listing see Table S3 ). In an in vivo assay that monitors secretion of the periplasmic protein alkaline phosphatase mutants of Classes I (Fig. 5C These data demonstrated that several of the SecY regions identified using the peptide array analysis are important for function in vivo and for cell viability.
SecA binding sites on SecY are essential for translocase catalysis
Is the in vivo defect of the SecY mutants attributable to compromised SecA-driven protein translocation? To this end, we analysed the in vitro translocation of the model preprotein substrate proOmpA into inner membrane vesicles (IMVs) containing wild-type SecYEG or mutant derivatives (Fig. 5D ). Class III SecY mutants (e.g. M2, lane 8) retained some, albeit reduced, translocation activity compared with wild-type SecY (lane 3), while no proOmpA translocation was detected with Class I or II mutants (e.g. M15 and M4; lanes 6 and 7) or with the uncomplemented secYcs strain (lane 5). Clearly, the SecY mutants severely compromise SecA-dependent protein translocation. This defect was not corrected by provision of proton motive force (data not shown).
Additionally, we examined the ability of SecY mutants to stimulate SecA basal ATPase at 37°C (Fig. 5E ) or 20°C (Fig. S3A) . In this assay, basal SecA ATPase is significantly stimulated upon addition of wild-type SecYEGcontaining IMVs (membrane ATPase; lane 2) or IMVs plus proOmpA (translocation ATPase; lane 3). All SecY mutant derivatives (lanes 6-17) or the uncompleted secYcs strain (lanes 4 and 5) fail to stimulate SecA basal ATPase at either temperature. Reduced membrane ATPase activity is suggestive of compromised interaction with SecYEG that could lead to suboptimal priming . This defect was further quantified by using a range of IMV concentrations for wild-type and three representa- SecADC (aa 1-609) were produced as independent polypeptides (Karamanou et al., 1999). tive SecY mutants (Fig. S3B) . Increasing the amount of added IMVs leads to an eightfold stimulation of SecA ATPase activity when wild-type SecY is used, while little or no stimulation is seen with the mutant IMVs.
We concluded that the SecY regions identified here are essential for a functional SecA-SecY interaction and subsequent SecA-mediated protein translocation.
SecA binding sites on SecY are essential for functional activation of SecA
Individually mutated sites of a polyvalent, discontinuous receptor would be expected to reduce the overall affinity of SecA for SecYEG. To test this hypothesis we quantified the affinity of [ 35 S]-SecA for IMVs carrying mutant SecY derivatives as described (Hartl et al., 1990; Vrontou et al., 2004) (Table 1 ; Fig. S4 ). Indeed, the affinity of SecA for IMVs containing Class I and II SecY mutants is reduced A. Map of mutations generated in this study and that display the strongest defects. The location of 11 of the mutations generated and the residues affected are indicated. For a complete list of the 21 mutations see Table S3 . B. In vivo genetic complementation analysis. Genetic complementation test, at 20°C, of the AF659 secYcs strain (Baba et al., 1990; Taura et al., 1994) . The strain was transformed with a vector carrying secY or secY mutants or with no insert as a control. AF659 secYcs transformants were cultured at 37°C until mid-log phase. Cells were serially diluted with LB and 6 ml of each was spotted on LB agar plates, which were photographed after 72 h at 20°C. Only four representative mutants are shown here. All strains grew fully at the permissive temperature of 37°C (not shown). C. Protein translocation in vivo. Plasmids encoding wild-type SecY or mutants M2, M4, M15 under the control of the ptrc promoter were introduced into E. coli strain JM109 (DE3) along with pBAD22 derivative plasmids encoding wild-type proPhoA under the control of the ara regulon. The cells were grown at 37°C until OD595 = 0.2. SecYEG synthesis was induced with 0.2 mM IPTG and phosphatase activity was measured at 414 nm using p-nitrophenol phosphate as a substrate. Activity units are defined as (OD414 ¥ 1000)/(OD595 ¥ incubation time) (Derman et al., 1993) . Background values from chromosomal SecYEG were determined in the same experiment and subtracted from the corresponding values of plasmid-expressed SecYEG. Error bars represent the standard deviation from measurements of three independent cultures each in triplicate. D. In vitro protein translocation. In vitro protein translocation of SecY and representative SecY derivatives. ATP-driven translocation of proOmpA-His (0.1 mg ml ) and translocation (IMVs plus 60 mg ml -1 proOmpA) ATPase activities of SecY and of its indicated derivatives were determined at 37°C. To exclude background values from the small amounts of the chromosomally encoded SecY, IMVs prepared from strain AF569 carrying the vector alone were also prepared. Values for these IMVs were determined in the same experiment and were subtracted from the corresponding values of the IMVs harbouring mutant SecYs. three-to fivefold. Therefore, the SecY regions identified here are required for efficient SecA-SecYEG assembly.
Discussion
We present the footprint of SecA binding to SecYEG. SecA associates almost exclusively with the charged cytoplasmic face of SecYEG forming several interactions (Fig. 2) . Five 'composite' SecYEG regions interact with the large SecA molecule ( Fig. 2A-F and Table S2 ). Each of these interactions is of low affinity (Fig. 1C) . Presumably, concomitant binding of SecA to multiple regions results in the high-affinity SecA-SecYEG complex (Hartl et al., 1990) . Such poly valent binding is typical when high-and lowaffinity states interchange in highly dynamic systems. This property could be critical for the flexible translocase.
SecA binds to SecYEG largely at cytoplasmic regions. Some of the sites identified here agree with partial peptide arrays (Robson et al., 2007) and engineered cysteine cross-linking (Mori and Ito, 2006) . Other sites localize on SecYEG residues that are near the trans side of the membrane and lie outside the preprotein channel. Such sites would be consistent with periplasmic exposure of SecA regions (den Blaauwen et al., 1997a; Ramamurthy and Oliver, 1997; Eichler and Wickner, 1998) and inserted intermediates. Alternatively, SecG could also interact with SecA at the cis side through regions such as b 2/b3 after invertion of its membrane topology (Nishiyama et al., 1996) .
Mutational analysis validated the importance of the SecA binding surfaces on SecY. Several of the mutations we generated result in strong functional defects in vivo ( Fig. 5B and C) and in vitro ( Fig. 5D and E; Fig. S3A ). Previous studies have also identified mutations in some of the binding sites identified here (Mori and Ito, 2001; Chiba et al., 2002; Smith et al., 2005; Tam et al., 2005) . Some of the mutations cause a measurable reduction (up to fivefold) in binding affinity (Table 1; Fig. S4 ), consistent with a role of the identified sites in SecA binding to SecY. This reduction is rather strong considering the multiplicity of the binding sites and the fact that their individual affinities for SecA are very low. We entertain two possibilities: contribution to SecA binding from the various sites is highly synergistic or, alternatively, minor conformational effects caused by the mutations might misalign the threedimensional orientation of the multiple weak binding sites.
Importantly, the various sites are not equally involved in binding under all regimes. Thus, three of the binding sites (e 1, a2/3 and d1) are used prominently by SecA under all conditions tested and would appear to be more 'static' anchors. The presence of such sites was anticipated as SecA binding to SecYEG does not require nucleotide or elevated temperature (Natale et al., 2004) (Fig. 3B-G) . All of the other observed interactions appear to be more 'dynamic' and vary in intensity depending on the experimental conditions. Nucleotides and temperature affect not only SecA conformation Sianidis et al., 2001; Hunt et al., 2002; Keramisanou et al., 2006) but also the strength of SecA binding to some SecYEG sites. For example, binding of SecA at e 1 is stronger in the AMP-PNP state at physiological temperature (Fig. 2F) , while nucleotides abolish binding at d2 at 4°C (Fig. 2B and C) . ADP binding promotes a more compact SecA state Sianidis et al., 2001; Hunt et al., 2002; Keramisanou et al., 2006) and this state is clearly less prone to hydrophobic interactions seen at 37°C (Fig. 2D) . Some of these interactions (e.g. d2, e2, b2/3) (Fig. 4A ) are susceptible to removal of extreme SecA regions such as the flexible, membraneinserting C-tail (den Blaauwen et al., 1997a) . The C-tail also controls SecA binding to preproteins and SecB (Breukink et al., 1995; den Blaauwen et al., 1997b; Randall et al., 2005) .
The C-domain binds prominently to SecYEG at 4°C (Fig. 4B ) but loses its binding at physiological temperature (not shown). Previous experiments failed to demonstrate binding of the isolated C-domain to SecYEG (Karamanou et al., 1999; Dapic and Oliver, 2000) . These data, together with the observation that the C-domain is particularly flexible (Song and Kim, 1997) and loses its structure at elevated temperature (I. Gelis and C.G. Kalodimos, unpubl. results), suggest that its interaction with SecY is dynamic.
Binding to SecYEG is the result of defined associations from both the N-terminal and the C-terminal regions of SecA (Fig. 4) . These data corroborate previous observations that both the C-domain region (Economou and Wickner, 1994; Economou et al., 1995) and the N-terminal region Ramamurthy and Oliver, 1997; Vrontou et al., 2004; Osborne and Rapoport, 2007) can interact with SecYEG. Some of the binding sites appear to be specific for the N-terminal region (e.g. a 1, g1, g2, d2) or the C-domain (e1, g4, d3). Remarkably, however, several of the binding sites on SecYEG share common residues between the C-domain and the N-terminal region of SecA (although differences in the degree of binding and the exact frame are apparent, e.g. compare binding to e2 in Fig. 4B and D) . We think this (Vrontou et al., 2004 might be due to the quaternary organization of SecYEG that is widely thought to function as a dimer (Bessonneau et al., 2002; Tziatzios et al., 2004; Osborne and Rapoport, 2007) and to the limited number (six) of cytoplasmic loops available for binding. The model of division of labour in the SecYEG dimer with one SecYEG functioning as a docking station for a single SecA and the other as a preproteinconducting channel (Osborne and Rapoport, 2007) would be in good agreement with our data (Fig. 6A) . Peptide array experiments cannot deconvolute the potential contributions from different SecYEG trimers. Alternative possibilities of a 'head-to-tail' SecA dimer docking on two SecYEG trimers (Fig. 6B) would also be compatible with independent C-domain and N-terminal region binding to a SecYEG dimer. However, we observed identical binding with either monomeric or dimeric SecA (not shown). In summary, we hypothesize that SecA makes use of both stable docking sites and numerous dynamic sites on the SecYEG dimer as it undergoes nucleotide-and preprotein-driven conformational changes during the translocation reaction. This allows SecA to remain constantly attached to SecYEG, probably with its N-terminal domain, while at the same time undergoing nucleotidedriven conformational changes that affect its business end, i.e. the two specificity domains. These interactions modulate the conformation of the protein-conducting channel and may push or guide segments of the preprotein across the membrane.
Experimental procedures
Strains and plasmids AF659, a derivative of E. coli strain MC4100, carries the SecY39 mutation (R357H) that renders the cells coldsensitive (Baba et al., 1990; Smith et al., 2005) . For construction of mutant SecY proteins see Supporting information.
Binding of SecA to peptide arrays
Peptide arrays were prepared by automated spot synthesis (Jerini Peptide Technologies GmbH) (Reineke et al., 2001) . Peptides were C-terminally attached to cellulose via a b-Ala spacer. Peptides were derived from protein sequences of E. coli SecY (1-145), secE (1-39) and secG (1-34). Each spot carries 5 nmol of peptide covalently bound to the cellulose PEG membrane. Before screening, the dry membrane was washed in methanol (10 min), in high-salt buffer (50 mM Trizma base pH 8, 6.4 mM KCl, 170 mM NaCl) at room temperature (3 ¥ 5 min), in buffer B (50 mM Trizma-base pH 8.0, 50 mM KCl, 5 mM MgCl2) at the desired temperature (5 ¥ 5 min) and finally in equilibration buffer (buffer B, 5 g of sucrose, 100 mg ml -1 BSA, 2 mM DTT, 0.01% Tween-20) (15 min).
SecA (100 nM) and SecA domains (200 nM) were allowed to react with the peptide array membrane for 1 h at 4°C or 15 min at 37°C respectively. Free SecA was removed with extended buffer B washes while SecA bound to peptides was electrotransferred onto PVDF membranes (Millipore). PVDF membranes were sandwiched between blotting papers soaked with cathode buffer (25 mM Trizma base, 40 mM aminocaproic, 20% methanol, 0.01% SDS, pH 9.2) and anode buffers ABI, ABII (ABI = 30 mM Trizma-base, 20% methanol, pH 10.5, ABII = 300 mM Trizma-base, 20% methanol, pH 10.5). Bound SecA was detected by a-SecA-specific polyclonal rabbit sera and enhanced chemiluminesence measurement (Pierce) using a fluoroimaging system (Fujifilm; LAS 3000). In order to account for lower-affinity proteinprotein interactions a range of dilutions of SecA antisera were used (1:100 000-1:8000). 'Binding Strength' of SecA on each spot was determined as described in Table S2 .
ATP hydrolysis measurements
All assays were in buffer B (50 mM Tris-Cl, pH 8, 50 mM KCl, 5 mM MgCl2, 1 mM DTT, 1 mg ml -1 BSA and 1 mM ATP). SecA was added at 0.1 mg ml -1 . For membrane ATPase IMVs containing SecY or SecY derivatives were added at 1.5 mg of SecY as determined by quantitative Western blots using purified SecY as a marker. For translocation ATPase proOmpA was further added at 20 mg ml -1 . Released phosphate and Kcat values were measured as described (Karamanou et al., 1999; Sianidis et al., 2001) .
SecA binding to membrane-embedded SecYEG
Binding of [
35 S]-labelled SecA to IMVs was performed as described elsewhere (Hartl et al., 1990) . Briefly, urea-treated IMVs (64 mg of membrane protein ml -1 ) were mixed with a range of [
35 S]-SecA concentrations (0.5-2000 nM; buffer B; 1 mg ml -1 BSA; 15 min; 4°C). Reactions were overlaid on equal volume of buffer B, 0.2 M sucrose, 1 mg ml -1 BSA, in centrifuge tubes pre-adsorbed with BSA and sedimented (320 000 g; 30 min; 4°C; Beckman TLX120 ultracentrifuge). Pellets, rinsed (twice; 100 ml of buffer B) and re-suspended Fig. 6 . Working models of SecA interaction to SecYEG. The models take into account data presented here and those from others (Mori and Ito, 2006; Osborne and Rapoport, 2007) with either a monomeric (A) or a dimeric 'head-to-tail' dimer (B) SecA binding to a dimeric SecYEG (yellow cylinders). SecA is depicted as an N-terminal domain (blue) binding to a C-terminal domain (green).
by sonication, were spotted on nylon membranes in a vacuum manifold (Bio-Rad). Bound radioactivity was quantified by phosphorimaging (Storm 840; GE Healthcare). Data were fitted to hyberbolae using non-linear regression in Prism (GraphPad). Binding using the flotation assay was as previously described (Papanikou et al., 2004) .
SecA binding to SecYEG-containing IMVs was also studied suing a flotation gradient centrifugation assay (Beck et al., 2000; Karamanou et al., 2005; Papanikou et al., 2005) . Binding of SecA (1 mg) to IMVs (100 mg of membrane protein) containing wild-type SecYEG or mutant derivatives was examined in buffer B as indicated. Following incubation (5 min; 4°C), the reactions (50 ml) were adjusted to a final concentration of 1.6 M sucrose in buffer B, and the resulting 150 ml of samples were overlaid with three consecutive layers of 1.4, 1.2, 0.25 M sucrose solutions. Following centrifugation (90 min; 436 000 g, TLA120.2 rotor, Beckman Optima TLX120) fractions of 50 ml were carefully removed, analysed by SDS-PAGE and visualized by immunostaining with a-SecA antibody.
In vivo complementation
In vivo genetic complementation of the cryosensitive AF659 secYcs strain was tested at 20°C (Baba et al., 1990; Taura et al., 1994) . AF659 was transformed with plasmids carrying secY or mutant derivatives. AF659 secYcs were cultured at 37°C until mid-log phase. Cells were serially diluted 10-fold with LB and 6 ml of each was spotted on LB agar plates, which were photographed after 12 h at 37°C and 72 h at 20°C.
Isothermal titration calorimetry
Isothermal titration calorimetry was used to measure changes in enthalpy (DH) and stoichiometries of soluble SecY peptides binding to SecA as described (Keramisanou et al., 2006 ) using a VP-ITC (Microcal) instrument and Origin 7.0 software. SecA was added to the cell at 80 mM and peptides were contained in the injection syringe at 1 mM and added in 20 ml increments.
Protein translocation
Protein translocation was studied in vitro using proOmpA as a model protein as described (Karamanou et al., 1999) . In vivo secretion was carried out using alkaline phosphatase as described (Derman et al., 1993; Osborne and Rapoport, 2007) .
Chemicals/biochemicals
Nucleotides were from Roche; DNA enzymes were from Minotech; oligonucleotides were from the IMBB genomics facility; dNTPs were from Promega. [
35 S]-Methionine (1000 Ci mmol -1 ) and chromatography materials (except Ni 2+ affinity; Qiagen) were from Amersham. Proteins were purified as described Karamanou et al., 1999) . Soluble SecY peptides were synthesized by Alta Bioscience (Birmigham), dissolved in DMSO (100%) and stored at -20°C.
